HUMA
Income statement / Annual
Last year (2023), Humacyte, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Humacyte, Inc.'s net income was -$110.78 M.
See Humacyte, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00 |
$1.57 M |
$1.26 M |
$1.49 M |
$6.19 M |
Cost of Revenue |
$76.55 M
|
$8.26 M
|
$49,000.00
|
$8.43 M
|
$75.60 M
|
Gross Profit |
-$76.55 M
|
-$6.69 M
|
$1.21 M
|
-$6.94 M
|
-$69.42 M
|
Gross Profit Ratio |
0
|
-4.27
|
0.96
|
-4.66
|
-11.22
|
Research and Development Expenses |
$76.55 M
|
$63.26 M
|
$61.34 M
|
$54.08 M
|
$75.60 M
|
General & Administrative Expenses |
$23.39 M
|
$22.88 M
|
$21.13 M
|
$12.01 M
|
$16.27 M
|
Selling & Marketing Expenses |
-$3.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$20.39 M
|
$22.88 M
|
$21.13 M
|
$12.01 M
|
$16.27 M
|
Other Expenses |
-$73.44 M
|
-$1.57 M
|
-$1.26 M
|
-$1.49 M
|
$0.00
|
Operating Expenses |
$23.50 M
|
$84.58 M
|
$81.21 M
|
$64.60 M
|
$16.28 M
|
Cost And Expenses |
$100.05 M
|
$84.58 M
|
$81.21 M
|
$64.60 M
|
$91.88 M
|
Interest Income |
$0.00
|
$2.63 M
|
$16,000.00
|
$278,000.00
|
$269,000.00
|
Interest Expense |
$1.13 M
|
$6.20 M
|
$4.35 M
|
$2.20 M
|
$2.30 M
|
Depreciation & Amortization |
$7.72 M
|
$8.26 M
|
$8.28 M
|
$8.43 M
|
$6.75 M
|
EBITDA |
-$96.46 M |
$2.49 M |
-$72.97 M |
-$56.25 M |
-$78.94 M |
EBITDA Ratio |
0
|
-102.46
|
-108.46
|
-37.54
|
-12.76
|
Operating Income Ratio |
0
|
-54.04
|
-64.3
|
-43.33
|
-13.85
|
Total Other Income/Expenses Net |
-$10.73 M
|
$72.61 M
|
$54.73 M
|
-$1.92 M
|
$269,000.00
|
Income Before Tax |
-$110.78 M
|
-$11.97 M
|
-$26.48 M
|
-$66.52 M
|
-$85.42 M
|
Income Before Tax Ratio |
0
|
-7.65
|
-20.96
|
-44.62
|
-13.81
|
Income Tax Expense |
$0.00
|
-$76.18 M
|
-$64.01 M
|
$2.20 M
|
$0.00
|
Net Income |
-$110.78 M
|
$64.22 M
|
$37.54 M
|
-$68.73 M
|
-$85.42 M
|
Net Income Ratio |
0
|
41.03
|
29.72
|
-46.09
|
-13.81
|
EPS |
-1.07 |
0.62 |
0.94 |
-5.52 |
-4.25 |
EPS Diluted |
-1.07 |
0.62 |
0.94 |
-5.52 |
-4.25 |
Weighted Average Shares Out |
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
Weighted Average Shares Out Diluted |
$103.42 M
|
$103.05 M
|
$39.97 M
|
$12.45 M
|
$20.12 M
|
Link |
|
|
|
|
|